The Defense Health Agency awarded a $398,107 Cooperative Agreement to the Metis Foundation, a non-profit organization, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year project to develop a multi-modal approach to reduce vascularized composite allotransplantation (VCA) immunogenicity and improve functional outcomes. The Metis Foundation has an extensive history providing medical research, products, and services through prime and sub...
This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
The Defense Health Agency awarded a $264,000 cooperative agreement to the Metis Foundation from September 30, 2022 to September 29, 2025 under the Military Medical Research and Development program (CFDA 12.420). The award will support the Metis Foundation's ACTIVE REJECTION MICRO-PATCH SURVEILLANCE (ARMS) SYSTEM FOR VASCULARIZED COMPOSITE ALLOGRAFTS project located in San Antonio, TX. Through this funding, the Metis Foundation will develop an ARMS system to monitor vascularized composite...
This $1,845,076 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports Metis Foundation, a non-profit organization in San Antonio, Texas, to conduct novel research on therapeutic approaches targeting the innate immune system for treating multiple organ failure in severe polytrauma during prolonged casualty care. The funding will enable Metis Foundation to develop advanced medical...
The federal Project Grant award of $1,034,071 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research by the Metis Foundation on "PROSTATE-SPECIFIC ANTIANDROGEN THERAPY FOR LOCALIZED PROSTATE CANCER." The research aims to develop innovative prostate cancer therapies, building upon Metis Foundation's expertise in conducting medical research, education, and project management support for the military health...
The Cooperative Agreement award of $1,987,608.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Metis Foundation in improving severe burn resuscitation outcomes through the use of icatibant, an FDA-approved bradykinin B2 receptor antagonist. This 2-year project, running from September 2023 to September 2025, aims to develop innovative medical technologies and conduct research to transform care for military service members...
The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...
The U.S. Uniformed Services University of the Health Sciences awarded a $847,096 Cooperative Agreement to the Metis Foundation under CFDA Program 12.750 Uniformed Services University Medical Research Projects. The purpose of the award is to support the remote monitoring of cardiopulmonary function using a rugged wearable tissue oximeter. Metis Foundation, a non-profit organization based in San Antonio, Texas, specializes in medical research, education, and project management support primarily...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...